FDA Inspection
AlloSourceAlloSource – FDA Inspection, Aug 30, 2022
Record Details
This FDA Inspection record concerns AlloSource, with an inspection on August 30, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- AlloSource
- Inspection Date
- August 30, 2022
- Product Type
- Biologics
View Company Profile
ID · d9f545b2-a5ac-43fa-b251-c0a13b52b2d3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1180198
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of AlloSource
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 5, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 12, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 28, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for AlloSource
- FDA Inspection 1012394 - 2017-05-22
- FDA Inspection 916763 - 2015-03-05
- FDA Inspection 771277 - 2012-03-12
- FDA Inspection 659873 - 2010-04-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.